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Background: Rabies virus (RABV) causes a fatal infection of the central nervous systems (CNS) of warm-blooded
animals. Once the clinical symptoms develop, rabies is almost invariably fatal. The mechanism of RABV pathogenesis
remains poorly understood. Recent studies have shown that microRNA (miRNA) plays an important role in the
pathogenesis of viral infections. Our recent findings have revealed that infection with laboratory-fixed rabies virus
strain can induce modulation of the microRNA profile of mouse brains. However, no previous report has evaluated
the miRNA expression profile of mouse brains infected with RABV street strain.
Results: The results of microarray analysis show that miRNA expression becomes modulated in the brains of mice
infected with street RABV. Quantitative real-time PCR assay of the differentially expressed miRNAs confirmed the
results of microarray assay. Functional analysis showed the differentially expressed miRNAs to be involved in many
immune-related signaling pathways, such as the Jak-STAT signaling pathway, the MAPK signaling pathway,
cytokine-cytokine receptor interactions, and Fc gamma R-mediated phagocytosis. The predicted expression levels of
the target genes of these modulated miRNAs were found to be correlated with gene expression as measured by
DNA microarray and qRT-PCR.
Conclusion: RABV causes significant changes in the miRNA expression profiles of infected mouse brains. Predicted
target genes of the differentially expression miRNAs are associated with host immune response, which may provide
important information for investigation of RABV pathogenesis and therapeutic method.
Keywords: Street strain rabies virus, Brain infection, MicroRNA profiling, Gene profiling, Target prediction, Functional
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The rabies virus (RABV), a member of the family Rhab-
doviridae, is a highly neurotropic virus that can cause
fatal infections of the central nervous systems (CNS) of
warm-blooded animals [1,2]. Although significant advances
have been made in rabies prevention and control, the
disease remains a major threat to public health. It* Correspondence: yst10223@yahoo.com.cn; xiaxianzhu@gmail.com
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Despite the catastrophic clinical outcome of RABV en-
cephalomyelitis, the histopathological changes observed in
the CNS are typically relatively mild, showing varying
degrees of mononuclear inflammatory cell infiltration of
the leptomenings, perivascular cuffing, microglial activa-
tion, and neuronophagia. Although there are several hy-
potheses under active study at present, the pathogenesis of
the rabies virus has not yet been determined.
MiRNA (miRNA, miR) is endogenous 22 nt RNA
that negatively regulates gene expression by translational
repression [4]. It binds to the complementary sequences
in the mRNAs and blocks the translation or accelerates
mRNA decay [5]. MiRNAs play key roles in cellulartd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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liferation, and hematopoiesis [6-9]. Recently, evidence
has demonstrated that cellular miRNAs exert regulatory
functions in virus-host interactions [10,11]. It is becom-
ing increasingly clear that miRNAs of cellular origin can
positively or negatively influence viral infection. For ex-
ample, miR-122 is indispensable to replication of the
hepatitis C virus (HCV), whereas miR-196 and miR-296
substantially attenuate viral replication [12,13]. A recent
study reported that miR-28, miR-125b, miR-150, miR-
223, and miR-382 inhibit replication of the human im-
munodeficiency virus (HIV) in CD4+ T cells [14].
Microarray analyses have been recently employed to
detect changes in host miRNA expression, which can help
reveal molecular pathways that govern viral pathogenesis.
By using miRNA microarray profiling, researchers haveFigure 1 Outcomes of mice infected with RABV Fujian strain. After i.c.
(B) copy number of RABV N mRNA were recorded as described in Material
were obtained from 8 mice (three mice for N mRNA) in each group. Data a
experiment. Similar results were obtained in three independent experimenobserved differentially expressed patterns of cellular miR-
NAs in the lungs of mice infected with influenza virus
[15]. Another study found miRNAs to be significantly
regulated in mouse brains upon Venezuelan equine en-
cephalitis virus (VEEV) infection [16]. Our own recent
findings suggest that infection with laboratory-fixed rabies
virus, ERA (Evelyn Rokitnicki Abelseth), can induce
modulation of the microRNA profile of the mouse brain
[17]. However, no report has yet been made regarding the
assessment of the host miRNA expression profile in
mouse brains upon infection with the street strain of
RABV.
In this study, we performed an expression profile of
cellular miRNAs in the brains of mice infected with the
highly pathogenic street rabies virus. Meawhile,we per-
formed target prediction and functional enrichment ofinjection of 105 ffu of street Fujian RABV strain, (A) clinical score and
s and Methods. Mice were monitored for survival for 21 days. Data
re the mean± standard deviation (SD) of one representative
ts.
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several miRNAs were modulated in mouse brains infected
with RABV. Finally, we performed gene microarray ana-
lysis and qRT-PCR measurement to verify the expression
levels of the predicted targets of the modulated miRNAs
in these pathways. The results of functional enrichment
revealed that many of the predicted targets of these miR-
NAs play key roles in the immune response, which are
known to be associated with the pathogenesis of RBAV.Results
Characterization of pathogenicity of RABV Fujian strain
in mice
All infected animals showed RABV-specific symptoms
that increased in severity in a time-dependent manner.
After inoculation, all mice developed the clinical signs of
disordered movement at 4 days post-infection (dpi). At 6
dpi, considerable aggravation of typical clinical signs
was observed, with the onset of trembling, shaking,
anger, and hyperexcitation followed by general paralysis
(Figure 1A). As presented in a previous study, out of all
infected animals, 12.5%, 25%, and 50% were dead at 6, 7,
and 8 dpi, respectively, and all mice succumbed to RABV
at or before 9 dpi [18]. Viral load in the brain wasFigure 2 MiRNA profile of street RABV-infected mouse brain. (A) Two-
miRNAs in three independent samples (P< 0.01). Each row shows the relati
expression level of a single sample. Up-regulated miRNAs are shown in red
differentially expressed miRNAs in mouse brain upon RABV infection by mi
fold change (FC)≥ 2 and P≤ 0.01 were considered significantly up-regulate
down-regulated.monitored up to 9 dpi using Taqman qRT-PCR
(Figure 1B). RABV replicated rapidly in brain with an in-
crease in copy number from 3 dpi and reached a maximal
viral load at 7 dpi. The results demonstrate that the RABV
Fujian strain is highly pathogenic in mice.Modulation of miRNA profile in brain in response to
RABV infection
To determine changes in miRNA expression in mouse
brains in response to street RABV infection, we evaluated
miRNA expression profiles at 7 dpi. The two-way hierarch-
ical cluster heat map clear showed different expression pat-
tern of host miRNAs between RABV and mock infections
(Figure 2A). MiRNAs whose relative expression levels
showed a fold change (FC)≥ 2 and P≤ 0.01 were consid-
ered significantly up-regulated, and those with FC≤−2 and
P≤ 0.01 were considered significantly down-regulated. As
shown in Figure 2B, nine miRNAs, miR-691, miR-377,
miR-1935, miR-190, miR-1902, miR-135a*, miR-203, miR-
2138, and miR-290-5p, were found to be significantly up-
regulated. However, only one miRNAs, miR-145, was
found to be down-regulated upon RABV infection. This
indicates that host miRNAs were modulated in the CNS
upon infection with street rabies virus.way hierarchical cluster heat map showing all significantly expressed
ve expression level of a single miRNA. Each column shows the
and down-regulated miRNAs are shown in green. Significantly
croarray analysis. MiRNAs whose relative expression levels showed a
d, and those with FC≤−2 and P≤ 0.01 were considered significantly
Zhao et al. Virology Journal 2012, 9:159 Page 4 of 13
http://www.virologyj.com/content/9/1/159Confirmation of differentially expressed miRNAs by
qRT-PCR
To validate the differential expression profiles of miRNAs
obtained by microarray analysis, quantitative RT-PCR was
performed on six selected differentially expressed miRNAs
including miR-691, miR-377, miR-1935, miR-190, miR-
203, and miR-145. The data demonstrate that the overall
results of qRT-PCR were consistent with those of the
microarray analysis. Although differences were observed
between these two types of analysis due to intrinsic dif-
ferences between the techniques, the qRT-PCR results
showed the same relative regulation of differentially
expressed miRNAs as the microarray data results
(Figure 3).
Target prediction and functional analysis of differentially
expressed miRNAs
Target genes regulated by these differentially expressed
miRNAs were predicted using TargetScan Mouse,
MicroCosm, and miRanda. For these ten differentially
expressed miRNAs, TargetScan predicted 2,058, Micro-
Cosm predicted 5,433 and miRanda predicted 29,742
target genes. Of these, 3,038 target genes were predicted
under all three systems (Additional file 1: Figure S1).
Gene ontology (GO) analysis in the Database for Anno-
tation, Visualization and Integrated Discovery (DAVID)
was performed for these miRNAs using the predicted
gene targets [19]. Functional analysis revealed 106 GO
terms to be involved in biological processes, 14 inFigure 3 Verification of differentially expressed miRNAs by
qRT-PCR. Six differentially expressed miRNAs were selected from
miRNA microarray datasets and examined by qRT-PCR. The fold
change from the qRT-PCR was determined using the 2-ΔΔCt method
and all miRNA expression values were normalized against the U6
endogenous control. Data from qRT-PCR are shown as
mean± standard deviation (SD) of one representative experiment.
Similar results were obtained in three independent experiments.molecular function, and 20 in cellular components
(P < 0.01) (Additional file 2: Table S1). The twenty most
common GO categories were cellular processes, meta-
bolic processes, cellular metabolic processes, macromol-
ecule metabolic processes, and cellular macromolecule
metabolic process (Figure 4). These analyses suggest that
cellular miRNAs may regulate cellular metabolic pro-
cesses during street RABV infection, either directly or
indirectly.
Pathway analysis of target genes of differentially
expressed miRNAs
To identify the biological pathways that become active
in the mouse brain in response to RABV infection, we
mapped the target genes of differentially expressed miR-
NAs to canonical signaling pathways in the Kyoto
Encyclopedia of Genes and Genomes (KEGG). The
results showed that 25 statistically remarkable categories
(P < 0.05) were enriched (Additional file 3: Table S2). As
shown in Table 1, the predicted target genes of six up-
regulated miRNAs, miR-691, miR-377, miR-1935, miR-
190, miR-203, and miR-135a*, and one down-regulated
miRNA, miR-145, were found to be involved in
immune-related pathways, such as the Jak-STAT signal-
ing pathway, MAPK signaling pathway, Fc gamma R-
mediated phagocytosis and cytokine-cytokine receptor
interactions. The predicted target genes of five up-
regulated miRNAs, miR-691, miR-377, miR-190, miR-203,
and miR-1290-5p, and one down-regulated miRNA, miR-
145, were found to be involved in other pathways, such as
the Adherens junction, Wnt signaling pathway, Axon
guidance, cell cycle, TGF-beta signaling pathway, and
Focal adhesion.
DNA microarray assay and qRT-PCR measurement of
miRNA targets
MiRNAs predominately function as repressors of target
gene expression. The miRNAs and their targets show
mutually antagonistic expression levels. To determine
whether any such correlation exists between deregulated
miRNA levels and their corresponding targets, we per-
formed DNA microarray assay and qRT-PCR validation.
To identify the genes involved in the pathways common
to miRNA target prediction and RABV infection, we
measured the expression of genes from Jak-STAT signal-
ing pathway (SOCS4), cytokine-cytokine receptor inter-
actions (IL25, CD40, VEGFA, and CCR10), MAPK
signaling pathway (MAPKAPK3), Fc gamma R-mediated
phagocytosis (ARF6), and Wnt signaling pathway
(NFAT5). As presented in Table 2, MAPKAPK3 and
IL25, the targets of up-regulated miRNA miR-691;
SOCS4, the target of up-regulated miRNAs miR-377;
CCR10 and NFAT5, the targets of up-regulated miRNA
miR-1935; VEGFA, the target of up-regulated miRNA miR-
Figure 4 Enriched GO terms in the biological process category among differentially expressed miRNAs. After miRNA microarray
assay, significantly enriched GO analysis in the biological process category was performed on differentially expressed genes in the brains of
RABV-infected mice using DAVID (P< 0.01). Only the top twenty GO terms are listed here. For other enriched GO terms, please see
Additional file 1: Table S1.
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290-5p, were found to be down-regulated. ARF6, the
target of down-regulated miRNA miR-145, was found
to be up-regulated. The negative correlation between
these miRNAs and their targets showed these pathways
to be part of the RABV infection response at the expres-
sion level. Together, these results strongly suggest that
certain miRNAs may be associated with RABV infection
and pathogenesis.
Discussion
RABV, a pathogen well-adapted to the nervous system,
infects the neurons of warm-blooded animals. Despite
the catastrophic clinical outcome of RABV encephalo-
myelitis, especially that caused by street viruses, the
histopathological changes observed in the CNS are typic-
ally relatively mild. CNS has more intrinsic mechanisms
for controlling immune response than other organs. In-
deed, many viral infections can be cleared from the CNS
by immune mechanisms [20]. This may indicate that,
upon viral infection, the immune privilege of the CNS is
not as strong as has been proposed [21].
In mammals, approximately 30% of all protein-coding
genes are predicted to be regulated by miRNAs [22].
Currently, nearly a thousand miRNAs have been cloned,
each potentially regulating hundreds of genes by
complementary binding to the 3′-untranslated region
(3′-UTR) of the target mRNAs. Recent publications haveprovided compelling evidence that a range of miRNAs
are involved in the regulation of immunity, including the
development and differentiation of B and T cells, prolif-
eration of monocytes and neutrophils, antibody switch-
ing and the release of inflammatory mediators [4,23-25].
More importantly, researchers have reported that cellu-
lar miRNAs play key regulatory roles during viral infec-
tion and that altered cellular miRNA expression in
response to viral infection may be an important deter-
minant of virulence [10,11,26].
Recently, our findings suggested that infection with
laboratory-fixed rabies virus strain, ERA, induced modu-
lation of microRNA profile of mouse brains [17]. In the
current study, a comprehensive examination of miRNA
expression from brains of street-RABV- and mock-
infected mice was performed. The results showed that
host miRNAs were modulated upon RABV infection.
We found that the expression profiles of host miRNAs
in mouse brains infected by these two strains of RABVs
were completely different from each other. Interestingly,
the same differences in transcriptome were observed be-
tween the mouse brains upon infection with the two
strains of RABVs, ERA and street RABV Fujian strain
(unpublished data) [18]. This discrepancy can be partly
attributed to differences in virulence of the viruses. Fur-
ther study is required to determine the correlation be-
tween specific miRNA expression and RABV virulence
using reverse genetics or RNA interference. Some
Table 1 Predicted targets of modulated miRNAs upon RABV infection involved in immune response pathways
miRNA KEGG pathway Target genes Number of
targets
P value
mmu-miR-377 mmu04630: Jak-STAT signaling pathway CSF2RB2, EP300, JAK2, SOCS4, BCL2L 5 0.01
mmu-miR-377 mmu04010: MAPK signaling pathway CACNA2D1, FASL, PPM1A, PPP3R1, RASA1, FLNC, PLA2G4A, SRF 8 0.02
mmu-miR-377 mmu04060: Cytokine-cytokine receptor
interaction
CSF2RB2, FASL, ACVR2A, VEGFA, IL18RAP, KITL, PDGFRA, LTB 8 0.001
mmu-miR-377 mmu04666: Fc gamma R-mediated
phagocytosis
WASF1, LIMK1, PRKCD, PLA2G4A, RPS6KB1 5 0.01
mmu-miR-377 mmu04520: Adherens junction WASF1, EP300, YES1, PVRL4, PTPRB, SMAD4 6 1.18E-06
mmu-miR-377 mmu04310: Wnt signaling pathway EP300, WNT5A, PPP3R1, FZD3, FZD4, AXIN1, BTRC, SMAD4,
CUL1, DKK1
10 3.62E-04
mmu-miR-377 mmu04360: Axon guidance PPP3R1, RASA1, LIMK1, SEMA6A, SEMA3D 5 0.001
mmu-miR-377 mmu04110: Cell cycle EP300, ESPL1, CDC26, CUL1 4 0.007
mmu-miR-377 mmu04350: TGF-beta signaling pathway EP300, ACVR2A, THBS1, PITX2, SMAD4, CUL1, LEFTY2, RPS6KB1 8 6.96E-06
mmu-miR-377 mmu04510: Focal adhesion MYLK2, XIAP, ITGA6, VEGFA, THBS1, PDGFRA, FLNC, LAMC1 8 0.018
mmu-miR-691 mmu04630: Jak-STAT signaling pathway GHR, SPRY2, TYK2, SPRED2, IL12A, CLCF1 6 0.01
mmu-miR-691 mmu04010: MAPK signaling pathway PLA2G10, MKNK2, MAPKAPK3, CACNB2, TGFBR2, DUSP9 5 0.02
mmu-miR-691 mmu04060: Cytokine-cytokine receptor
interaction
GHR, ACVR2A, BMP2, IL25, AMHR2, IL12A, TGFBR2, TNFSF14, CLCF1 9 0.001
mmu-miR-691 mmu04666:Fc gamma R-mediated
phagocytosis
LYN, INPP5D 2 0.01
mmu-miR-691 mmu04520: Adherens junction CSNK2B, SRC, CDH1, TGFBR2 4 1.18E-06
mmu-miR-691 mmu04310: Wnt signaling pathway DKK2, CSNK2B, CAMK2G, CTBP2, VANGL1 5 3.62E-04
mmu-miR-691 mmu04360: Axon guidance PTK2, SEMA6D, ABLIM1, NRP1, PLXNA2, SRGAP3, SEMA5A 7 0.001
mmu-miR-691 mmu04110: Cell cycle YWHAB, TFDP1 2 0.007
mmu-miR-691 mmu04350: TGF-beta signaling pathway ACVR2A, BMP2, THBS1, AMHR2, TFDP1, SP1, TGFBR2 7 6.96E-06
mmu-miR-691 mmu04510: Focal adhesion PTK2, IBSP, ITGA10, PGF, CAPN2, THBS1, SRC 7 0.018
mmu-miR-1935 mmu04630: Jak-STAT signaling pathway LIFR, SPRY3 2 0.01
mmu-miR-1935 mmu04010: MAPK signaling pathway MAP3K12, FLNC, MAPT 3 0.02
mmu-miR-1935 mmu04060: Cytokine-cytokine receptor
interaction
ACVR1, HGF, LIFR, CCR10 4 0.001
mmu-miR-1935 mmu04666: Fc gamma R-mediated
phagocytosis
MARCKS 1 0.01
mmu-miR-1935 mmu04520: Adherens junction YES1, PVRL1 2 1.18E-06
mmu-miR-1935 mmu04310: Wnt signaling pathway NFAT5 1 3.62E-04
mmu-miR-1935 mmu04360: Axon guidance NFAT5, PLXNA4, SRGAP2, DCC 4 0.001
mmu-miR-1935 mmu04110: Cell cycle STAG1, CDKN1C 2 0.007
mmu-miR-1935 mmu04510: Focal adhesion FLNC 1 0.018
mmu-miR-190 mmu04630: Jak-STAT signaling pathway IL6 1 0.01
mmu-miR-190 mmu04010: MAPK signaling pathway FASL, PLA2G6, BDNF, FGF14 4 0.02
mmu-miR-190 mmu04060: Cytokine-cytokine receptor
interaction
FASL, HGF, IL6, CXCL16 4 0.001
mmu-miR-190 mmu04666: Fc gamma R-mediated
phagocytosis
PLA2G6, ARPC5 2 0.01
mmu-miR-190 mmu04520: Adherens junction SMAD2, TJP1 2 1.18E-06
mmu-miR-190 mmu04310: Wnt signaling pathway SMAD2, PPP2R1B, ROCK1, PLCB1 4 3.62E-04
mmu-miR-190 mmu04360: Axon guidance EPHA1, ROCK1 2 0.001
mmu-miR-190 mmu04110: Cell cycle SMAD2, CHEK1, RBL1 3 0.007
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Table 1 Predicted targets of modulated miRNAs upon RABV infection involved in immune response pathways
(Continued)
mmu-miR-190 mmu04350: TGF-beta signaling pathway SMAD2, PPP2R1B, PITX2, ROCK1, RBL1 5 6.96E-06
mmu-miR-190 mmu04510: Focal adhesion CAPN2, HGF, ROCK1 3 0.018
mmu-miR-135a* mmu04630: Jak-STAT signaling pathway EP300,IL24,IFNAR2,IL12RB1,IFNG 5 0.01
mmu-miR-135a* mmu04060: Cytokine-cytokine receptor
interaction
IL24,IFNAR2,IL12RB1,IFNG,CXCL16,CD40LG 6 0.001
mmu-miR-135a* mmu04666: Fc gamma R-mediated
phagocytosis
NCF1 1 0.01
mmu-miR-135a* mmu04520: Adherens junction EP300, ACTN2 2 1.18E-06
mmu-miR-135a* mmu04310: Wnt signaling pathway EP300, WNT1, PPP2R1A 3 3.62E-04
mmu-miR-135a* mmu04110: Cell cycle EP300, YWHAQ, ANAPC7 3 0.007
mmu-miR-135a* mmu04350: TGF-beta signaling pathway EP300, BMP4, IFNG, PPP2R1A 4 6.96E-06
mmu-miR-135a* mmu04510: Focal adhesion PTEN, ITGA8, ACTN2 3 0.018
mmu-miR-290-5p mmu04630: Jak-STAT signaling pathway IL13RA1, IFNGR2, AKT1, CSF2RB 4 0.01
mmu-miR-290-5p mmu04010: MAPK signaling pathway GADD45A, MAPKAPK3, MEF2C, MAP3K1, AKT1FGF23 5 0.02
mmu-miR-290-5p mmu04060: Cytokine-cytokine receptor
interaction
IL13RA1, IL18R1, CD40, IFNGR2, CXCL12, ACVR1B, CSF2RB 7 0.001
mmu-miR-290-5p mmu04666: Fc gamma R-mediated
phagocytosis
MARCKS, AKT1 2 0.01
mmu-miR-290-5p mmu04520: Adherens junction LMO7, ERBB2, PTPRB, LEF1, INSR, SSX2IP, PVRL3 7 1.18E-06
mmu-miR-290-5p mmu04310: Wnt signaling pathway LEF1, CAMK2G, PLCB1, AXIN2 4 3.62E-04
mmu-miR-290-5p mmu04360: Axon guidance ROBO1, L1CAM, SEMA5B, CXCL12 4 0.001
mmu-miR-290-5p mmu04110: Cell cycle SMC3, MCM5, GADD45A, CDC25A, TFDP1, HDAC2, RAD21, ORC5L 8 0.007
mmu-miR-290-5p mmu04350: TGF-beta signaling pathway TFDP1 1 6.96E-06
mmu-miR-290-5p mmu04510: Focal adhesion XIAP, ERBB2, AKT1 3 0.018
mmu-miR-203 mmu04630: Jak-STAT signaling pathway IL24, CNTFR, IL22RA2, CCND1, SOCS3, AKT2, IL12B 7 0.01
mmu-miR-203 mmu04010: MAPK signaling pathway CACNA2D1, MAP3K13, DUSP5, MAP4K3, STK3, NLK, AKT2, ATF2,
PDGFRA, RAP1A, MAPT, MAP3K1, PPM1B, FGF7, CRK, PRKCA
16 0.02
mmu-miR-203 mmu04060: Cytokine-cytokine receptor
interaction
MET, IL24, CNTFR, ACVR2A, IL22RA2, VEGFA, XCL1, PDGFRA, IL12B 9 0.001
mmu-miR-203 mmu04666: Fc gamma R-mediated
phagocytosis
PLD2, AKT2, DNM1L, PPAP2B, CRK, VAV3, PRKCA 7 0.01
mmu-miR-203 mmu04520: Adherens junction MET, NLK, SRC, PTPRB, SNAI2 5 1.18E-06
mmu-miR-203 mmu04310: Wnt signaling pathway SFRP2, CCND1, NLK, APC, CSNK1A1, CUL1, PRKCA 7 3.62E-04
mmu-miR-203 mmu04360: Axon guidance MET, ABL1, SEMA3A, SEMA6A, SEMA5A 5 0.001
mmu-miR-203 mmu04110: Cell cycle YWHAQ, CCND1, ABL1, SKP2, CUL1 5 0.007
mmu-miR-203 mmu04350: TGF-beta signaling pathway ACVR2A, ID2, BMP5, CUL1, ID4 5 6.96E-06
mmu-miR-203 mmu04510: Focal adhesion MET, PXN, CCND1, VEGFA, PPP1C, SRC, PDGFRA, RAP1A, RAPGEF1,
TNC, COL4A4, CAV1, CRK, VAV3, PRKCA
15 0.018
mmu-miR-145 mmu04630: Jak-STAT signaling pathway MYC, STAM, STAT4, SOCS7 4 0.01
mmu-miR-145 mmu04010: MAPK signaling pathway MAP3K3, HSPA1L, PPP3CA, DUSP4, MYC, RASA2, RAPGEF2, FLNB,
DUSP6, TGFBR2, MAP4K4, CRKL
12 0.02
mmu-miR-145 mmu04060: Cytokine-cytokine receptor
interaction
FLT3L, TNFRSF11B, IL17RB, INHBB, ACVR1B, TGFBR2 6 0.001
mmu-miR-145 mmu04666:Fc gamma R-mediated
phagocytosis
ARF6, CFL2, LAT, ARPC5, CRKL 5 0.01
mmu-miR-145 mmu04520: Adherens junction YES1, ERBB2, CTNND1, ACTG1, SMAD3, ACTB, TGFBR2 7 1.18E-06
mmu-miR-145 mmu04310: Wnt signaling pathway PPP3CA, FZD9, MYC, CTNNBIP1, SMAD3, SENP2, WNT5B 7 3.62E-04
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(Continued)
mmu-miR-145 mmu04360: Axon guidance PPP3CA, CFL2, SRGAP1, DPYSL2, SEMA3, EFNB3, SRGAP2, ABLIM2,
SEMA6A, PLXNA2, SEMA3D
11 0.001
mmu-miR-145 mmu04110: Cell cycle MCM5, MYC, SMAD3, CDK6, SFN, ORC2L 6 0.007
mmu-miR-145 mmu04350: TGF-beta signaling pathway MYC, SMAD3, INHBB, TGFBR2, SMAD5 5 6.96E-06
mmu-miR-145 mmu04510: Focal adhesion ERBB2, ACTG1, FLNB, ACTB 4 0.018
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the modulations in miRNA expression that occur in re-
sponse to viral infection. For example, Li and colleagues
performed miRNA profiling in the lungs of mice
infected with influenza and found that cellular miRNA
might be a contributing factor to the extreme virulence
of the influenza virus [15]. Bhomia and colleagues sug-
gested that host miRNAs were significantly modulated
in mouse brains upon VEEV infection [16].
Although many computational approaches have been
developed to predict miRNA targets using sequence in-
formation, their accuracy is limited [27-30]. To increase
reliability, we used three web-based target prediction
databases, TargetScan, MicroCosm, and Targets. The
pathways listed in Table 1 and Additional file 3: Table S2
are among the most significant, as indicated by predic-
tions from all three algorithms. It has been shown that
miRNA-induced down-regulation of target genes pro-
vides opportunities to develop new approaches to target
identification and validation using high-throughput ex-
pression profiling [31]. Gene expression profiling data
have been used to identify functional targets of miRNAs
[32-34]. MiRNAs and the mRNAs that they target for
degradation can be expected to exhibit an inverse ex-
pression relationship. Researchers established a strategy
for miRNA target identification using these inverse rela-
tionships as predicted from the paired expression profiles
[35]. In our recently published work, we also identified





(Fold: " or #)
qRT-PCR
(Fold: " or #)
mmu-miR-691 MI0004659 25.29×," 16.71 ± 3.24×,"
mmu-miR-691 MI0004659 25.29×," 16.71 ± 3.24×,"
mmu-miR-377 MI0000794 12.90×," 11.22 ± 2.87×,"
mmu-miR-1935 MI0009924 10.06×," 9.94 ± 2.63×,"
mmu-miR-1935 MI0009924 10.06×," 9.94 ± 2.63×,"
mmu-miR-203 MI0000246 2.79×," 3.73 ± 1.42×,"
mmu-miR-290-5p MI0000388 2.44×," 6.79 ± 2.31×,"
mmu-miR-145 MI0000169 0.40×,# 4.82 ± 1.58×,#
Data from qRT-PCR are shown as mean± standard deviation (SD) of one representa
experiments.predicted from the paired expression profiles [17]. In the
present study, we simultaneously collected miRNA and
DNA microarray data from the same samples and com-
pared the predicted targets of significantly modulated
miRNAs to the gene expression profiles of RABV-infected
mouse brains. This showed that some of the predicted
miRNA targets were correlated with the mRNA expres-
sion profile.
Host defense against viral invasion requires induction
of appropriate innate immune responses. Upon recogni-
tion of viral components, host cells become activated
and produce type I IFN and proinflammatory cytokines
[36,37]. A suitable amount of type I interferon (IFN)
induces cellular resistance to viral infection and apop-
tosis of virus-infected cells [38]. However, viruses have
developed several strategies to evade and subvert the im-
mune responses mediated by type I IFN, including har-
nessing host miRNAs. A recent study demonstrated that
the vesicular stomatitis virus (VSV), family Rhabdoviri-
dae, can induce up-regulation of miR-146a, which
feedback-inhibits RIG-I-dependent IFN-I production in
macrophages [39]. In our study, enrichment of KEGG
pathways revealed that the predicted target genes of dif-
ferentially expressed miRNAs upon RABV infection may
involve Jak-STAT signaling pathway. The Jak-STAT path-
way is initiated in response to cytokines, such as inter-
leukins and IFNs, and growth factors. To invasive innate
immune response of host, RABV interrupts IFN Jak-STAT







(Fold: " or #)
qRT-PCR
(Fold: " or #)
MAPKAPK3 NM_178907 1.57×,# 10.02 ± 4.11×,#
IL25 NM_080729 1.45×,# 12.75 ± 2.91×,#
SOCS4 NM_080843 1.35×,# 9.52 ± 2.56×,#
CCR10 NM_007721 1.39×,# 4.58 ± 2.03×,#
NFAT5 NM_133957 1.59×,# 7.69 ± 3.17×,#
VEGFA NM_001025257 1.37×,# 4.87 ± 1.96×,#
CD40 NM_011611 1.3×,# 5.43 ± 2.76×,#
ARF6 NM_007481 1.21×," 5.38 ± 2.77×,"
tive experiment. Similar results were obtained in three independent
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modulated miRNAs were found to be involved in Jak-
STAT signaling, including JAK2, SOCS4, which are targets
of miR-377; TYK2 and IL12A, targets of miR-691; IL6, a
target of miR-190; IFNAR2, a target of miR-135a*;
IFNGR2 and AKT1, targets of miR-290-5p; and SOCS3
and AKT2, targets of miR-203. This suggests that the Jak-
STAT pathway may be affected by RABV-inducible cellu-
lar miRNAs (Table 1).
Recent studies have revealed the important regulatory
roles played by cytokines and their receptors in RABV
infection. One study showed that over-expression of
cytokine CCL3 (MIP-1α) in mouse brains decreased
RABV pathogenicity [41]. The same research team also
demonstrated that MIP-1α not only reduces viral patho-
genicity but also enhances immunogenicity by recruiting
dendritic cells and B cells to the sites of immunization,
lymph nodes, and blood [42]. We observed that several
targets of differentially expressed miRNAs are involved in
cytokine-cytokine receptor interaction. These included
FASL, IL18RAP, and KITL, which are targets of miR-377;
IL25, IL12A, TNFSF14, and CLCF1, which are targets of
miR-691; CCR10, a target of miR-1935; CXCL16, a target
of miR-190; IL24, IFNG, CXCL16, and CD40LG, targets of
miR-135a*; IL18R1, CD40, CXCL12, and CSF, targets of
miR-290-5p; and IL24, XCL1, and IL12B, targets of miR-
203 (Table 1). Our findings showed that modulated miR-
NAs may regulate the functions of cytokines during
RABV infection.
The MAPK signaling pathway has been shown to regu-
late the expression of genes involved in the immune re-
sponse to pathogens. Viral infection can induce activation
of the MAPK signaling pathway [43,44]. RABV infection
induces MAPK and NF-κB activation, which have been
found to regulate chemokine expression in microglial cells
[45]. Some key MAPK signaling pathway-related target
genes were identified in the present study. These included
SPRED2, a target of miR-691, MAP3K12, a target of miR-
1935, MAPKAPK3 and MAP3K1, targets of miR-290-5p,
and MAP3K13, MAP4K3, and MAP3K1, targets of miR-
203 (Table 1). This demonstrated that RABV-induced cel-
lular miRNAs might be involved in the MAPK signaling
pathway after RABV infection.
In summary, the results of the present study provide
evidence that specific miRNAs are modulated in the
street-RABV-infected brain. This result was found to be
completely different from the expression profiles of host
miRNAs in the CNS of mice infected with the
laboratory-fixed strains of RABV. Considering that this
was verified by both DNA microarray and qRT-PCR, we
suggest that the modulated miRNAs might affect the
biological processes of cells during RABV infection. Our
study suggests that host miRNAs might be an important
class of targets and may play a key role in regulatinggene expression in response to highly pathogenic RABV
infection of the CNS.
Conclusion
In summary, our findings suggested that street RABV in-
fection resulted in significant changes in the expression
of multiple miRNAs in mouse brains. The modulated
miRNAs might regulate biological processes of cells dur-
ing RABV infection. The predicted target genes of these
differentially expressed miRNAs are involved in immune
responses in the host. MiRNA and mRNA profiles
obtained in this study might help elucidate the regula-




RABV street rabies virus Fujian strain, isolated from a
rabid dog in Fujian Province, was used for this study.
Viral stocks were prepared as described elsewhere with
minor modifications [46]. Briefly, Three-day-old suckling
mice were intracerebrally (i.c.) infected with 30 μl of
viral sample. When moribund, mice were euthanized
and brains were removed. A 10% (wt/vol) suspension
was prepared by homogenizing the brain in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco CA, U.S.). The
homogenate was centrifuged to remove debris, and the
supernatant was collected and stored at −80°C. The viral
titers were determined in triplicate on monolayer cul-
tures of mouse neuroblastoma cell (NA) as described
previously [47].
Animal infection and assessment of clinical signs
Six-to-eight-week-old female BALB/c mice were obtained
from the Changchun Institute of Biological Products,
China. Animals had access to food and water ad libitum.
All the experiments with live virus challenge were carried
out at the bio-safety level 2 (BSL-2) facilities of the Key La-
boratory of Jilin Province for Zoonosis Prevention and
Control, Institute of Military Veterinary, Academy of Mili-
tary Medical Sciences.
The animal experiments were conducted with prior
approval from the Animal Welfare and Ethics Committee
of Institute of Military Veterinary, Academy of Military
Medical Sciences under the permit number (SCXK-
2002-018). All manipulation of the mice satisfied the
requirements of the Regulations of Experimental Animal
Administration of China.
Mice in the experimental mice were infected with 105
focus-forming units (FFU) of RABV in 30 μl of DMEM
via the i.c. route. Mice in the control group were mock-
infected i.c. with DMEM containing uninfected brain
homogenates for use as controls. Infected animals were
observed twice daily for 21 days for the development of
Zhao et al. Virology Journal 2012, 9:159 Page 10 of 13
http://www.virologyj.com/content/9/1/159rabies. Disease progression and mortality were moni-
tored. Clinical signs were scored as described elsewhere
using a scale of 0 to 5: 0, no clinical signs; 1, disordered
movement; 2, ruffled fur, hunched back; 3, trembling
and shaking; 4, complete loss of motion (complete par-
alysis); 5, death [48].Tissue collection and total RNA isolation
Tissue collection and total RNA isolation were performed
as described elsewhere [18]. Briefly, mice at 7 dpi were
anesthetized with ketamine-xylazine (1.98 and 0.198 mg
per mouse, respectively) and euthanized. Brains were har-
vested and stored in RNAlater (Ambion TX, U.S.) at −80°C
for total RNA extraction. Total RNAs were isolated from
the entire homogenized brains using the mirVanaTM
miRNA Isolation Kit (Ambion TX, U.S.). The integrity of
total RNA was analyzed by Agilent 2100 Bioanalyzer
(Agilent Technologies, CA, U.S.).Taqman PCR quantification of viral loads
To determine viral load in infected brain tissues, Taq-
Man qRT-PCR was performed on RNA samples using
Custom TaqManW Gene Expression Assays (Applied
Biosystems, CA, U.S.). The primers specific to the N gene
of the RABV Fujian strain (forward: 5′-GTGGGTACTGT
TGTCACTGCTTA-3′ and reverse: 5′-GTGAGATTTAT
CTGCTTTATGAACCCTGTA-3′) and probe (FAM-
TCCTGAGCAATCTTC-NFQ) and the protocols for
TaqMan qRT-PCR were used as described by our previous
study [18]. The TaqMan PCR was performed using Bril-
liant II qPCR Master Mix (Agilent Technologies, CA, U.S.)
in an Mx3005P apparatus (Agilent Technologies, CA, U.S.)
according to the manufacturer’s instructions. TaqMan runs
of experimental samples contained at least three replicates
with no-template or no-primer controls. Real-time PCR
was performed in reaction mixtures including 12.5 μl of 2×
QPCR master mix (Agilent Technologies, CA, U.S.), 1 μl
of 20× Custom TaqManW Gene Expression Assays (Ap-
plied Biosystems, CA, U.S.), 0.375 μl of diluted reference
dye (Agilent Technologies, CA, U.S.), and nuclease-free
PCR-grade water to a final volume of 25 μl. The PCR
conditions were (i) 95°C for 2 minutes and (ii) 40 cycles
of 95°C for 5 seconds and 60°C for 20 seconds. A standard
curve was generated from serially diluted RABV N RNAs
of known copy numbers, and the copy numbers of sam-
ples were normalized to 1 μg of total RNA. An absolute
standard curve method was to calculate the copy numbers
of RABV N mRNA in mouse brain tissue [49]. To exclude
contamination of genomic DNA, control cDNA reactions
in which reverse transcriptase was omitted were prepared
in parallel as described elsewhere [50]. These were uni-
formly negative.μParaflo miRNA microarray assays
Three RABV-infected and mock-infected mice at 7 dpi
were randomly selected for miRNA microarray analysis.
μParaflo miRNA microarray assays were outsourced to
LC Sciences (Houston, TX, U.S.). The assay was per-
formed on a 5 μg total RNA sample, which was size-
fractionated using a YM-100 Microcon centrifugal filter
(Millipore, MA, U.S.). The small RNAs (<300 nt) isolated
were 3′-extended with poly-(A) tails using poly-(A)
polymerases. An oligonucleotide tag was then ligated to
each poly-(A) tail for later fluorescent dye staining.
Hybridization was performed overnight on a μParaflo
microfluidic chip using a micro-circulation pump (Atactic
Technologies, TX, U.S.) [51,52]. The microfluidic chips
each contained a detection probe consisting of a chem-
ically modified nucleotide coding segment complementary
to target microRNA (from miRBase, http://microrna.san-
ger.ac.uk/sequences/) or other RNA (control or customer
defined sequences) and a spacer segment of polyethylene
glycol to extend the coding segment away from the sub-
strate. The detection probes were made by in situ syn-
thesis using PGR (photogenerated reagent) chemistry.
The hybridization melting temperatures were balanced
by chemical modifications of the detection probes.
Hybridization used 100 μl 6xSSPE buffer (0.90 M NaCl,
60 mM Na2HPO4, 6 mM EDTA, pH 6.8) containing
25% formamide at 34°C. Post-hybridization detection
used fluorescence labeling with tag-specific Cy5 dyes.
Hybridization images were collected using a laser scan-
ner GenePix 4000B (Molecular Devices) and digitized
using Array-Pro image analysis software (Media Cyber-
netics, MD, U.S.). Raw data were obtained for further
analysis.DNA microarray assays
Three mice at 7 dpi were randomly selected from the
RABV- and mock-infected groups for DNA microarray
analysis. mRNA microarray assays were outsourced to Phal-
anx Biotech Group. Inc. (Hsinchu, Taiwan). Fluorescence-
labeled cRNA was prepared from 5 μg of total RNA using
a Message AMPTM aRNA Kit (Ambion, TX, U.S.) and
Cy5 dye (Amersham Pharmacia, NJ, U.S.). Fluorescent tar-
gets were hybridized to the Mouse OneArrayTM Whole
Genome DNA microarray (Phalanx, Hsinchu, Taiwan)
containing 31,802 oligonucleotides, including 29,922
mouse genome probes, and 1,880 experimental control
probes. After an overnight hybridization at 50°C, non-
specific binding targets were washed in three different
washing steps, and the slides were dried by centrifuga-
tion and scanned using an GenePix 4000B (Molecular
Devices, CA, U.S.). The Cy5 fluorescent intensity of each
spot was analyzed using GenePix 4.1 (Molecular Devices,
CA, U.S.). Raw data were obtained for further analysis.
Table 3 Primers for selected genes analyzed using quantitative real-time PCR
Gene symbol Gene title Forward primer 5′! 3′ Reverse primer 5′! 3′ Amplicon (bp)
MAPKAPK3 Mitogen-activated protein kinase-activated
protein kinase 3
TATTATGTGGCTCCTGAGGTCCT TCATCTTCCCACCCTTAGGT 112
IL25 Interleukin 25 TGCTTGGAGCGCAGGCTCTA AGAGAGGGTTGGCCCGTA 113
SOCS4 Suppressor of cytokine signaling 4 ATGTTGAAATTCCTCTAAGAAG CGTAGAACGTCAAAGACAAATT 124
CCR10 Chemokine (C-C motif) receptor 10 ACCCAGTGTCTCCCTGATG TTCCAGTCGGTCCCGGTTGA 136
NFAT5 Nuclear factor of activated T-cells 5 CACCTTCTTCCCCCATTTTAT GTCTTTCAAAAAGGGTTAA 122
VEGFA Vascular endothelial growth factor A CCTATTCCCCTCTTAAATCGT AGGAACTGAAGAGAGACCT 125
CD40 CD40 antigen TCGGCTTCTTCTCCAATCAGT TGAAATTTGGTGTCTACTGT 126
ARF6 ADP-ribosylation factor 6 GGAAGGTGCTATCCAAGATCTT TAACCGGGTCGAAGTTGAACAT 108
GAPDH Glyceraldehyde-3-phosphate dehydrogenase CTCAACTACATGGTCTACATGTTC ATTTGATGTTAGTGGGGTCTCGCTC 142
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The protocols for qRT-PCR of miRNAs and mRNAs
were used as described in our previous study [17]. The
expression of specific miRNAs was analyzed with
quantitative real-time PCR using a LNATM-based qRT-
PCR kit, miRCURY LNATM Universal RT microRNA
PCR System (Exiqon, Denmark) according to manufac-
turer’s instructions. Total RNA from brain tissues of
RABV-infected and mock-infected mice was converted
to cDNA using universal reverse transcriptase primers
(Exiqon, Denmark). cDNA samples were diluted 1:80
in nuclease-free water and then PCR was amplified
using SYBR Green Master Mix and specific LNATM
miRNA primers (Exiqon, Denmark) for mmu-miR-691
(target sequence AUUCCUGAAGAGAGGCAGAAAA),
mmu-miR-377 (target sequence AUCACACAAAGGCA
ACUUUUGU), mmu-miR-1935 (target sequence AGG
CAGAGGCUGGCGGAUCUCU), mmu-miR-190 (target
sequence UGAUAUGUUUGAUAUAUUAGGU), mmu-
miR-203 (target sequence GUGAAAUGUUUAGGACC
ACUAG), and mmu-miR-145 (target sequence GUCC
AGUUUUCCCAGGAAUCCCU). Samples were run in
duplicate on an Mx3005P QPCR system (Agilent Tech-
nologies, CA, U.S.). The data were normalized to a U6
RNA control (Exiqon, Denmark) and relative expression
was calculated using the 2-ΔΔCt method [53].
For mRNA quantitative real-time PCR, reverse tran-
scription was performed using a Reverse Transcription
System (Promega, WI, U.S.) according to manufacturer’s
instructions. The names of the genes and their primers
are given in Table 3. Real-time PCR was performed
using BrilliantW II SYBRW Green QPCR Master Mix
(Agilent Technologies, CA, U.S.) in an Mx3005P QPCR
system (Agilent Technologies, CA, U.S.) according to
the manufacturer’s instructions. Expression of the gene of
interest was normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The expression levels of genes
were measured in terms of threshold cycle value (CT)
using the 2-ΔΔCt method [53].Microarray data analysis
Data from microarrays were analyzed as described in
our previous study [17]. First, raw data from both
miRNA and DNA microarrays, with replicates, were
averaged. Probes with median detection P value > 0.05
and flags reported as absent were filtered out. Expression
data were normalized using a variance stabilizing
method VSN in a Bioconductor (http://www.bioconduc-
tor.org) [54]. Differential expression of miRNAs were
assessed by eBayes (Empirical Bayes Statistics) from
LIMMA [55]. Differentially expressed miRNAs with
P < 0.01 were selected for further analysis. Microarray
data of miRNA and target genes were found to be
MIAME compliant and have been submitted to the
Gene Expression Omnibus (GEO) database (http://www.
ncbi.nlm.nih.gov/geo/; accession number: GSE26269
(miRNA data); GSE26270 (mRNA data)).
Target prediction and functional enrichment of
differentially expressed miRNAs
Target prediction and functional enrichment of differen-
tially expressed miRNAs were completed as described in
our previous study [17]. Three continuously updated
miRNA target prediction databases, TargetScan, Micro-
Cosm Targets, and miRanda, were used to infer the targets
of differentially expressed miRNAs. The intersection of
these datasets was taken as reliable. Gene ontology (GO)
category and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway analyses of target genes of differentially
expressed miRNAs were performed using the web-based
tool, Database for Annotation, Visualization, and Inte-
grated Discovery (DAVID, http://david.abcc.ncifcrf.gov/)19.
Additional files
Additional file 1: Figure S1. Target prediction of differentially
expressed miRNAs upon RABV infection. Three databases TargetScan,
MicroCosm Targets, and miRanda, were used to infer the targets of
differentially expressed miRNAs.
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targets of differentially expressed miRNAs.
Additional file 3: Table S2. Significantly enriched KEGG pathways of
differential expressed miRNAs in mouse brain upon RABV infection.
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